Search

everythinglearnresearchcommunity

for

Search:↓

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Finasteride is more effective and satisfactory than montelukast for treating moderate acne in women.

People with seborrheic dermatitis often have lower vitamin D levels.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.

Certain RNAs may help diagnose alopecia areata by affecting keratin genes.

Tissue-specific variation in mutant load complicates genetic counseling and prenatal diagnosis.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

AMT may cause hair loss and changing dWAT activity could help treat it.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Many COVID-19 survivors experience long-lasting symptoms, including hair loss and psychological issues.

Natural killer cells play a key role in autoimmune skin diseases like pemphigus vulgaris.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

TREM2 macrophages and unsaturated lipids contribute to acne inflammation.

Differences in skin and gut bacteria may contribute to alopecia areata.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

COVID-19 infection may trigger alopecia areata in some patients.

Oxidative stress is likely important in causing telogen effluvium, and antioxidants might help treat it.

Problems with arginine processing in hair follicles might contribute to common hair loss, and arginine supplements could help treat it.

Estrogen therapy helped regrow hair in a bald man.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

RNAi-based biopesticides could be safe and effective for pest control with careful development and risk assessment.

Five molecular elements identified as potential future targets for hair loss therapy.

The rapid corticotropin test is a quick and simple way to diagnose adrenal insufficiency.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.